ImmunityBio (IBRX) Convertible Debt (2022 - 2026)
ImmunityBio (IBRX) recorded Convertible Debt of $774.35 million in Q2 2026, up 57.4% from $492.08 million a year earlier and up 14.1% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Convertible Debt (2022 - 2026) Analysis & Trends
At the end of FY2025, ImmunityBio reported Convertible Debt of $477.09 million.
- Annual Convertible Debt has a three-year compound annual growth rate of 25.5% (FY2022 to FY2025).
- Across earlier years, Convertible Debt came in at $576.95 million in FY2023 (+139.1%) and $241.27 million in FY2022.
- The Q2 2026 figure is the highest quarterly Convertible Debt in data going back to Q4 2022.
- On a year-over-year basis, Convertible Debt rose in three of the last six quarters, with growth averaging 51.0%.
- Peak year-over-year performance for Convertible Debt in the last five years was growth of 255.7% in Q3 2024, against a decline of 16.3% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $678.39 million (Q1 2026), $477.09 million (Q4 2025) and $500.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.33 Bn | 1,106.91 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 618.82 Bn | 537.35 Bn | 17.26 Bn |
| 3 | AbbVie | 503.36 Bn | 476.47 Bn | 12.70 Bn |
| 4 | Merck | 369.59 Bn | 323.96 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.57 Bn | 262.56 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.25 Bn | 234.94 Bn | 12.86 Bn |
| 7 | Amgen | 237.35 Bn | 192.75 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.27 Bn | 165.47 Bn | 6.22 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn |
| 10 | ImmunityBio | 9.11 Bn | 7.87 Bn | 50.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 774.35 Mn |
| Mar 31, 2026 | 678.39 Mn |
| Dec 31, 2025 | 477.09 Mn |
| Sep 30, 2025 | 500.80 Mn |
| Jun 30, 2025 | 492.08 Mn |
| Mar 31, 2025 | 485.72 Mn |
| Sep 30, 2024 | 587.98 Mn |
| Jun 30, 2024 | 584.11 Mn |
| Mar 31, 2024 | 580.45 Mn |
| Dec 31, 2023 | 576.95 Mn |
| Sep 30, 2023 | 165.29 Mn |
| Jun 30, 2023 | 250.10 Mn |
| Dec 31, 2022 | 241.27 Mn |
API Access
ImmunityBio Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();